Wellbutrin Smoking Cessation Period Statistics

In this post, we present a compilation of key statistics on the effectiveness of Wellbutrin (Bupropion) for smoking cessation. These statistics shed light on the success rates, response rates, and outcomes associated with using Wellbutrin as a tool to quit smoking. From doubling the chances of successful quitting to specific success rates among different demographic groups, these statistics offer valuable insights for individuals considering Wellbutrin as a smoking cessation aid.

Statistic 1

"Wellbutrin (Bupropion) doubles the chances of quitting smoking successfully."

Statistic 2

"Bupropion increases long-term smoking abstinence rates by approximately 1.6 fold."

Statistic 3

"About 25% of smokers successfully stay off cigarettes after 1 year of treatment with Wellbutrin."

Statistic 4

"Successful quitting rate with bupropion alone is around 33%, and with additional nicotine replacement therapy is around 40%."

Statistic 5

"Wellbutrin significantly improves the likelihood of smoking cessation for women by 50.8%."

Statistic 6

"Among adolescent smokers, 12.5% reported complete abstinence after treatment with Wellbutrin."

Statistic 7

"Efficacy of Wellbutrin for smoking cessation in adolescents is comparatively lower, at around 10-12.5%."

Statistic 8

"It is estimated that about 33% of smokers suffer from depression and Wellbutrin has shown efficacy both as an antidepressant and smoking cessation aid."

Statistic 9

"The response rate for bupropion treatment in men for smoking cessation is approximately 26.7%."

Statistic 10

"After 4 weeks of bupropion treatment, 47% of patients reported complete smoking cessation."

Statistic 11

"In a study, the overall abstinence rates ranged from 19.1% to 44.2% in bupropion-treated groups."

Statistic 12

"Approximately 25% of patients using Wellbutrin for smoking cessation report side effects including dry mouth and insomnia."

Statistic 13

"Individuals using bupropion for smoking cessation have a 25.7% success rate over placebo at 4 weeks of treatment."

Statistic 14

"In a double-blind study, 142 subjects treated with wellbutrin showed a continuous abstinence rate of 44% from week 4 to 7 of treatment."

In conclusion, the statistics highlighted demonstrate the efficacy of Wellbutrin (Bupropion) as a smoking cessation aid, particularly in increasing the success rates of quitting smoking among individuals. Wellbutrin has shown to double the chances of successfully quitting smoking and significantly improve long-term smoking abstinence rates. The medication is especially beneficial for women, with a 50.8% increase in smoking cessation likelihood. While side effects and varying response rates exist, overall, Wellbutrin has consistently shown promise in helping individuals achieve and maintain smoking cessation goals.